000 01405 a2200373 4500
005 20250513172301.0
264 0 _c19930115
008 199301s 0 0 eng d
022 _a0168-8510
024 7 _a10.1016/0168-8510(92)90002-s
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHailey, D M
245 0 0 _aEvaluation and policy considerations in the introduction of extracorporeal membrane oxygenation.
_h[electronic resource]
260 _bHealth policy (Amsterdam, Netherlands)
_cOct 1992
300 _a287-95 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAustralia
650 0 4 _aClinical Trials as Topic
650 0 4 _aConsensus Development Conferences as Topic
650 0 4 _aCost-Benefit Analysis
_xstatistics & numerical data
650 0 4 _aExtracorporeal Membrane Oxygenation
_xeconomics
650 0 4 _aHealth Policy
650 0 4 _aHospital Planning
650 0 4 _aHospitals, Pediatric
_xorganization & administration
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aInfant, Newborn
650 0 4 _aTechnology Assessment, Biomedical
_xorganization & administration
650 0 4 _aTreatment Outcome
650 0 4 _aUnited States
700 1 _aSlatyer, B
773 0 _tHealth policy (Amsterdam, Netherlands)
_gvol. 22
_gno. 3
_gp. 287-95
856 4 0 _uhttps://doi.org/10.1016/0168-8510(92)90002-s
_zAvailable from publisher's website
999 _c10082293
_d10082293